GLP-1 analogs would be expected to exacerbate postprandial hyperinsulinemia in horses with ID, however incretin-independent actions have been demonstrated in other species for GLP-1 analogs such as exenatide [10]. This evidence concerns the gene GLP1R and Hyperinsulinemia.